Dublin, March 13, 2017 -- Research and Markets has announced the addition of the "Global Markets for Animal Therapeutics and Diagnostics" report to their offering.
The Global Market for Animal Therapeutics and Diagnostics Totaled Nearly $40.1 Billion in 2016 and Should Total $47.9 billion in 2021, Registering a CAGR
Report Includes:
- An overview of the global markets for animal therapeutics and diagnostics
- Analyses of global market trends, with data from 2015 and 2016, and projections of compound annual growth rates (CAGRs) through 2021
- Details about products currently in the market
- Analysis of the competitive environment
- A look at keys to market success including identifying the next growth segment, developing the right product candidates, and being the first to market
- Analysis of the market's dynamics, specifically growth drivers, inhibitors, and opportunities
- Profiles of major players in the industry
This report is designed to be a helpful business tool that will provide a thorough evaluation of the animal therapeutics and diagnostics market. The geographical scope of this study is worldwide, with special interest for markets, trends and statistics by key geographical regions such as the United States, European countries and Brazil, Japan and Australia.
The report identifies markets in four segments: vaccines, pharmaceuticals, feed additives and diagnostics. For the purpose of this study, diagnostics include products that are used at the point of care and are considered rapid tests or kits, in-clinic analyzers and imaging equipment. Each market segment provides detailed information based on product categories, use of products, forecasts and competitive analyses.
Key Topics Covered:
1: Introduction
- Study Goals And Objectives
- Reasons For Doing The Study
- Intended Audience
- Scope Of Report
- Information Sources
2: Summary
- Market Overview
- Leading Manufacturers And Suppliers
3: Industry Overview
- Animal Anatomy And Physiology
- Animal Populations In The United States
- Animal Populations By Country
- Zoonotic Diseases
4: Issues Affecting The Market
- Overview
- Legal And Regulatory Issues
- Biotechnology In Animal Health
- Animal Obesity
- Trends In Companion Pet Ownership
- Animal Health Insurance
- Advanced Medical Procedures
- Life Cycle Approach
- Demand In The Veterinary Service Industry
5: Animal Vaccines
- Overview
- Global Market Analysis And Considerations
- Product Introduction
- Companion Animals
- Production Animals
6: Animal Pharmaceutical Products
- Overview
- Global Market Analysis And Considerations
- Product Introductions
7: Animal Feed Additives
- Overview
- Global Market Analysis And Considerations
- Product Introductions
8: Animal Diagnostics
- Overview
- Global Market Analysis And Conclusion
- Product Providers And Descriptions
- Product Segments
9: Market Summary
- Global Animal Therapeutics And Diagnostics Market Analysis
- Competitive Analysis
10: Patent Analysis
- Overview
- Innovation In Drug Delivery
- Patent Product Segments
11: Company Profiles
- Overview
- Profiles
For more information about this report visit http://www.researchandmarkets.com/research/55rpw3/global_markets
CONTACT: Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Related Topics: Animal Healthcare/Veterinary, Animal Pharmaceuticals


Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Lockheed Martin Secures $328.5 Million U.S. Defense Contract for Advanced Systems Supporting Taiwan Air Force
Bain Capital Moves to Acquire Majority Stake in Echo Marketing
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
Drugmakers Plan 2026 U.S. Price Increases on Over 350 Branded Medications Despite Political Pressure
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Meta Acquires AI Startup Manus to Expand Advanced AI Capabilities Across Platforms
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Boeing Secures Major $2.7 Billion U.S. Military Contract for Apache Helicopter Support 



